| Literature DB >> 15015598 |
Aldo Andreani1, Massimiliano Granaiola, Alberto Leoni, Alessandra Locatelli, Rita Morigi, Mirella Rambaldi, Gianluca Giorgi, Vida Garaliene.
Abstract
We report the synthesis of new guanylhydrazones from imidazo[2,1-b]thiazoles and of a bis-guanylhydrazone from diimidazo[1,2-a:1,2-c]pyrimidine. The compounds were tested as potential antitumor agents at the National Cancer Institute. Two derivatives are now under review by BEC: one of these was also subjected to a test for positive inotropic activity in view of a possible coanthracyclinic activity. Tyrosine kinase receptors may be involved as molecular targets in the mechanism of action of the guanylhydrazones described.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15015598
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480